Lansoprazole and Sovaldi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lansoprazole (lansoprazole) and Sovaldi (sofosbuvir). Common drug interactions include anaemia among females and hepatocellular carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Lansoprazole and Sovaldi. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Lansoprazole?

Lansoprazole has active ingredients of lansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 129,663 Lansoprazole users. Check the latest studies of Lansoprazole.

What is Sovaldi?

Sovaldi has active ingredients of sofosbuvir. eHealthMe is studying from 12,697 Sovaldi users. Check the latest studies of Sovaldi.

On Jul, 20, 2026

65 people who take Lansoprazole and Sovaldi together, and have interactions are studied.

Lansoprazole and Sovaldi drug interactions.

What are the common drug interactions of Lansoprazole and Sovaldi, by gender? *:

female:

Anaemia (lack of blood)
Ataxia (loss of full control of bodily movements)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cardiac failure congestive
Dyspnoea (difficult or laboured respiration)
Hyperthyroidism (over activity of the thyroid gland)
Mitral valve incompetence (inefficient heart valve)
Tremor (trembling or shaking movements in one or more parts of your body)
Arthralgia (joint pain)
Balance disorder

male:

Hepatocellular carcinoma (liver cancer)
Renal impairment (severely reduced kidney function)
Bradycardia (abnormally slow heart action)
Dizziness
Hepatic vein thrombosis (obstruction in the veins of the liver caused by a blood clot)
Pyrexia (fever)
Rash
Sinus node dysfunction (a group of abnormal heart rhythms)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

What are the common drug interactions of Lansoprazole and Sovaldi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Hepatic vein thrombosis (obstruction in the veins of the liver caused by a blood clot)
Hepatocellular carcinoma (liver cancer)
Hepatic neoplasm (liver tumour)
Thrombosis (formation of a blood clot inside a blood vessel)

40-49:

Hepatic neoplasm (liver tumour)
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Sepsis (a severe blood infection that can lead to organ failure and death)
Psychotic disorder
Death

50-59:

Anaphylactic reaction (serious allergic reaction)
Arthralgia (joint pain)
Ataxia (loss of full control of bodily movements)
Chest pain
Cold sweat
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Hepatitis c
Pyrexia (fever)
Rash

60+:

Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Hypertransaminasaemia
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bone density decreased
Bone pain
Cardiac failure congestive
Cytomegalovirus infection
Emotional distress
Gait disturbance
Hepatocellular carcinoma (liver cancer)

What are the existing conditions these people have? *

Hepatitis C: 24 people, 36.92%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 14 people, 21.54%
High Blood Pressure: 7 people, 10.77%
Diabetes: 7 people, 10.77%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 6.15%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 4 people, 6.15%

* Approximation only. Some reports may have incomplete information.

Do you take Lansoprazole and Sovaldi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously